Chinese Journal of Arteriosclerosis 2025;33(8):721-728
doi:10.20039/j.cnki.1007-3949.2025.08.011
Progress in the treatment of endothelial dysfunction in atherosclerosis
Xinyu ZHANG 1 ; Ziyue XIE ; Zi'an WANG ; Yu LI ; Ruigong ZHU
Affiliations
Keywords
atherosclerosis; endothelial dysfunction; pharmacotherapy
Country
China
Language
Chinese
Abstract
Atherosclerosis is a chronic vascular wall disease.The clinical manifestations are abnormal lipid depo-sition,fibrous hyperplasia,calcium deposition,etc.under the intima of the affected artery lesions.Its initial link is re-lated to endothelial cell dysfunction,which can be triggered and aggravated by different risk factors of atherosclerosis,in-cluding oxidative stress,hemodynamic abnormalities,endothelial cell senescence and inflammation,etc.Exploring the mechanism of endothelial cell dysfunction is conducive to the discovery of potential treatments for atherosclerosis.This ar-ticle summarizes the mechanism and research progress of drug therapy for endothelial cell dysfunction in atherosclerosis.
备案号: 11010502037788, 京ICP备10218182号-8)